Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

This is an ongoing Phase 1 clinical trial evaluating BL-M17D1 in patients with HER2-positive or low-HER2-expression gastrointestinal cancers and other solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• BL-M17D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Esophageal Cancer, Gastric Cancer | Phase 1 | Status: RECRUITING